Find a metastatic breast cancer trial that's right for you.
Play Video
How does Metastatic Trial Search work?
Answer questions about your diagnosis
View matched trials in patient-friendly language
Login/Register at any time and save your profile to receive Trial Alerts
GET STARTED HERE
New to Clinical Trials?
New to Clinical Trials?
The idea of finding and entering a clinical trial can seem daunting. Use the following links to get started on the path to finding a trial that might be right for you.
- National Cancer Institute: What Are Clinical Trials?
- American Cancer Society: Clinical Trials–What You Need to Know
- Cancer.Net: Clinical Trials
- Living Beyond Breast Cancer: Clinical Trials: What They Are, Who Participates and Why It Matters
- Triage Cancer: Webinar: Clinical Trials 101
- Breastcancer.org: Expanded Access and Right to Try: Alternative Paths to Experimental Treatments for Metastatic Breast Cancer
- Susan G Komen: Clinical trials information helpline
- MBC Alliance: MBC Clinical Trials 101
NEWS & PUBLICATIONS
Metastatic Breast Cancer Research and Clinical Trials.
The latest clinical trials, research, and treatment options for you to share and discuss with your doctor.
SPECIAL TOPICS
Trial Alerts: Now Available on Metastatic Trial Search!
Read about our new feature, Trial Alerts, which are emails sent once a week when new trials posted on Metastatic Trial Search match your…
RESEARCH NEWS
Dato-DXd Antibody-Drug Conjugate for Triple-Negative and Hormone Receptor-Positive MBC
Learn about how ADCs work and for research news about…
FROM THE EXPERTS
Managing Side Effects of ADCs
Hear from experts about strategies to help prevent or reduce side effects to increase the ability to stay on treatment and improve quality of life…
Additional Links and Resources
The latest clinical trials, research, and treatment options for you to share and discuss with your doctor.
40-site U.S. trial enrolling more than 300 patients could significantly change the way DCIS is treated and reduce possibly unnecessary surgery
After years of watching women diagnosed with the disease get the same, drastic treatment of disfiguring surgery or brutal chemotherapy and radiation, Esserman believed doctors not only could but should be able to do better.
Quantum Leap Healthcare Collaborative™ today announced that Arvinas’ vepdegestrant (ARV-471), a novel PROTAC® estrogen receptor (ER) protein degrader being co-developed with Pfizer Inc. will be evaluated in the ongoing I-SPY TRIAL endocrine program sponsored by Quantum Leap.
Quantum Leap Healthcare Collaborative (QLHC) announces the mobile responsive launch of its metastatic breast cancer clinical trial matching service, Metastatic Trial Search (MTS). This launch expands MTS's reach to a broader range of breast cancer patient groups with a goal of reaching a more diverse population including those under-represented in clinical trials.
A leap in research happens with world-class partners.
We are grateful to our Platinum, Gold, Silver, and Bronze sponsors for their generous support.
